{"id":1742228,"date":"2023-05-27T04:51:24","date_gmt":"2023-05-27T03:51:24","guid":{"rendered":"https:\/\/www.pressenza.com\/?p=1742228"},"modified":"2023-05-27T04:51:24","modified_gmt":"2023-05-27T03:51:24","slug":"fda-aprueba-ensayos-de-microchips-en-humanos","status":"publish","type":"post","link":"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/","title":{"rendered":"FDA aprueba ensayos de microchips en humanos"},"content":{"rendered":"<p>La Administraci\u00f3n estadounidense de Medicamentos y Alimentos (FDA) autoriz\u00f3 a la empresa Neuralink, del fundador de Tesla, Elon Musk, a ensayar implantes cerebrales en humanos, pese a las cr\u00edticas por los ensayos en animales.<\/p>\n<p>El estudio y desarrollo del microchip dur\u00f3 tres a\u00f1os y tiene fines m\u00e9dicos para casos de par\u00e1lisis o enfermedades neurol\u00f3gicas. Este tendr\u00e1 una simbiosis con la IA (inteligencia artificial) y luego de la autorizaci\u00f3n de la FDA pasar\u00e1 a un reclutamiento para los ensayos cl\u00ednicos.<\/p>\n<p>El dise\u00f1o consiste en crear dispositivos con el fin de que el cerebro interact\u00fae directamente con ordenadores.<\/p>\n<p>Los primeros ensayos con monos tuvieron fuertes cr\u00edticas debido a que si bien, varios primates fueron capaces de \u00abjugar\u00bb videojuegos o \u00abtipear\u00bb palabras solo con seguir el movimiento de un cursor, el Comit\u00e9 de M\u00e9dicos para la Medicina Responsable se\u00f1al\u00f3 \u201csufrimiento extremo\u201d y \u201cefectos de salud bastante debilitantes\u201d en los animales sometidos al experimento.<\/p>\n<p>Foto: AMMI Technologies.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La Administraci\u00f3n estadounidense de Medicamentos y Alimentos (FDA) autoriz\u00f3 a la empresa Neuralink, del fundador de Tesla, Elon Musk, a ensayar implantes cerebrales en humanos, pese a las cr\u00edticas por los ensayos en animales. El estudio y desarrollo del microchip&hellip;<\/p>\n","protected":false},"author":831,"featured_media":1742229,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[76,497,11389,39,106739,1239],"tags":[113157,24495,113156,113158],"class_list":["post-1742228","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-relaciones-exteriores","category-ciencia-tecnologia","category-contenido-original","category-internacional","category-noticia","category-salud","tag-experimentos-en-animales","tag-inteligencia-artificial","tag-microchip-en-humanos","tag-neuralink-es"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FDA aprueba ensayos de microchips en humanos<\/title>\n<meta name=\"description\" content=\"La Administraci\u00f3n estadounidense de Medicamentos y Alimentos (FDA) autoriz\u00f3 a la empresa Neuralink, del fundador de Tesla, Elon Musk, a ensayar implantes\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA aprueba ensayos de microchips en humanos\" \/>\n<meta property=\"og:description\" content=\"La Administraci\u00f3n estadounidense de Medicamentos y Alimentos (FDA) autoriz\u00f3 a la empresa Neuralink, del fundador de Tesla, Elon Musk, a ensayar implantes\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/\" \/>\n<meta property=\"og:site_name\" content=\"Pressenza\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/PressenzaItalia\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-27T03:51:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pressenza.com\/wp-content\/uploads\/2023\/05\/ammi-technologies.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"930\" \/>\n\t<meta property=\"og:image:height\" content=\"620\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Redacci\u00f3n Per\u00fa\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@PressenzaIPA\" \/>\n<meta name=\"twitter:site\" content=\"@PressenzaIPA\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Redacci\u00f3n Per\u00fa\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/\"},\"author\":{\"name\":\"Redacci\u00f3n Per\u00fa\",\"@id\":\"https:\/\/www.pressenza.com\/es\/#\/schema\/person\/e86c29a41185b85084a478822f5de81b\"},\"headline\":\"FDA aprueba ensayos de microchips en humanos\",\"datePublished\":\"2023-05-27T03:51:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/\"},\"wordCount\":173,\"publisher\":{\"@id\":\"https:\/\/www.pressenza.com\/es\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.pressenza.com\/wp-content\/uploads\/2023\/05\/ammi-technologies.jpg\",\"keywords\":[\"experimentos en animales\",\"Inteligencia Artificial\",\"microchip en humanos\",\"Neuralink\"],\"articleSection\":[\"Asuntos internacionales\",\"Ciencia y Tecnolog\u00eda\",\"Contenido Original\",\"Internacional\",\"Noticia\",\"Salud\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/\",\"url\":\"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/\",\"name\":\"FDA aprueba ensayos de microchips en humanos\",\"isPartOf\":{\"@id\":\"https:\/\/www.pressenza.com\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.pressenza.com\/wp-content\/uploads\/2023\/05\/ammi-technologies.jpg\",\"datePublished\":\"2023-05-27T03:51:24+00:00\",\"description\":\"La Administraci\u00f3n estadounidense de Medicamentos y Alimentos (FDA) autoriz\u00f3 a la empresa Neuralink, del fundador de Tesla, Elon Musk, a ensayar implantes\",\"breadcrumb\":{\"@id\":\"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/#primaryimage\",\"url\":\"https:\/\/www.pressenza.com\/wp-content\/uploads\/2023\/05\/ammi-technologies.jpg\",\"contentUrl\":\"https:\/\/www.pressenza.com\/wp-content\/uploads\/2023\/05\/ammi-technologies.jpg\",\"width\":930,\"height\":620,\"caption\":\"Biometrics digital transformation with futuristic microchip remixed media\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.pressenza.com\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA aprueba ensayos de microchips en humanos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.pressenza.com\/es\/#website\",\"url\":\"https:\/\/www.pressenza.com\/es\/\",\"name\":\"Pressenza\",\"description\":\"International Press Agency\",\"publisher\":{\"@id\":\"https:\/\/www.pressenza.com\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.pressenza.com\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.pressenza.com\/es\/#organization\",\"name\":\"Pressenza\",\"url\":\"https:\/\/www.pressenza.com\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.pressenza.com\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.pressenza.com\/wp-content\/uploads\/2022\/10\/pressenza_logo_200x200.jpg\",\"contentUrl\":\"https:\/\/www.pressenza.com\/wp-content\/uploads\/2022\/10\/pressenza_logo_200x200.jpg\",\"width\":200,\"height\":200,\"caption\":\"Pressenza\"},\"image\":{\"@id\":\"https:\/\/www.pressenza.com\/es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/PressenzaItalia\",\"https:\/\/x.com\/PressenzaIPA\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.pressenza.com\/es\/#\/schema\/person\/e86c29a41185b85084a478822f5de81b\",\"name\":\"Redacci\u00f3n Per\u00fa\",\"description\":\"News published by the Pressenza bureau in Peru\",\"url\":\"https:\/\/www.pressenza.com\/es\/author\/redaccion-peru\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA aprueba ensayos de microchips en humanos","description":"La Administraci\u00f3n estadounidense de Medicamentos y Alimentos (FDA) autoriz\u00f3 a la empresa Neuralink, del fundador de Tesla, Elon Musk, a ensayar implantes","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/","og_locale":"es_ES","og_type":"article","og_title":"FDA aprueba ensayos de microchips en humanos","og_description":"La Administraci\u00f3n estadounidense de Medicamentos y Alimentos (FDA) autoriz\u00f3 a la empresa Neuralink, del fundador de Tesla, Elon Musk, a ensayar implantes","og_url":"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/","og_site_name":"Pressenza","article_publisher":"https:\/\/www.facebook.com\/PressenzaItalia","article_published_time":"2023-05-27T03:51:24+00:00","og_image":[{"width":930,"height":620,"url":"https:\/\/www.pressenza.com\/wp-content\/uploads\/2023\/05\/ammi-technologies.jpg","type":"image\/jpeg"}],"author":"Redacci\u00f3n Per\u00fa","twitter_card":"summary_large_image","twitter_creator":"@PressenzaIPA","twitter_site":"@PressenzaIPA","twitter_misc":{"Escrito por":"Redacci\u00f3n Per\u00fa","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/#article","isPartOf":{"@id":"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/"},"author":{"name":"Redacci\u00f3n Per\u00fa","@id":"https:\/\/www.pressenza.com\/es\/#\/schema\/person\/e86c29a41185b85084a478822f5de81b"},"headline":"FDA aprueba ensayos de microchips en humanos","datePublished":"2023-05-27T03:51:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/"},"wordCount":173,"publisher":{"@id":"https:\/\/www.pressenza.com\/es\/#organization"},"image":{"@id":"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pressenza.com\/wp-content\/uploads\/2023\/05\/ammi-technologies.jpg","keywords":["experimentos en animales","Inteligencia Artificial","microchip en humanos","Neuralink"],"articleSection":["Asuntos internacionales","Ciencia y Tecnolog\u00eda","Contenido Original","Internacional","Noticia","Salud"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/","url":"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/","name":"FDA aprueba ensayos de microchips en humanos","isPartOf":{"@id":"https:\/\/www.pressenza.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/#primaryimage"},"image":{"@id":"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pressenza.com\/wp-content\/uploads\/2023\/05\/ammi-technologies.jpg","datePublished":"2023-05-27T03:51:24+00:00","description":"La Administraci\u00f3n estadounidense de Medicamentos y Alimentos (FDA) autoriz\u00f3 a la empresa Neuralink, del fundador de Tesla, Elon Musk, a ensayar implantes","breadcrumb":{"@id":"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/#primaryimage","url":"https:\/\/www.pressenza.com\/wp-content\/uploads\/2023\/05\/ammi-technologies.jpg","contentUrl":"https:\/\/www.pressenza.com\/wp-content\/uploads\/2023\/05\/ammi-technologies.jpg","width":930,"height":620,"caption":"Biometrics digital transformation with futuristic microchip remixed media"},{"@type":"BreadcrumbList","@id":"https:\/\/www.pressenza.com\/es\/2023\/05\/fda-aprueba-ensayos-de-microchips-en-humanos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.pressenza.com\/es\/"},{"@type":"ListItem","position":2,"name":"FDA aprueba ensayos de microchips en humanos"}]},{"@type":"WebSite","@id":"https:\/\/www.pressenza.com\/es\/#website","url":"https:\/\/www.pressenza.com\/es\/","name":"Pressenza","description":"International Press Agency","publisher":{"@id":"https:\/\/www.pressenza.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pressenza.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.pressenza.com\/es\/#organization","name":"Pressenza","url":"https:\/\/www.pressenza.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pressenza.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.pressenza.com\/wp-content\/uploads\/2022\/10\/pressenza_logo_200x200.jpg","contentUrl":"https:\/\/www.pressenza.com\/wp-content\/uploads\/2022\/10\/pressenza_logo_200x200.jpg","width":200,"height":200,"caption":"Pressenza"},"image":{"@id":"https:\/\/www.pressenza.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/PressenzaItalia","https:\/\/x.com\/PressenzaIPA"]},{"@type":"Person","@id":"https:\/\/www.pressenza.com\/es\/#\/schema\/person\/e86c29a41185b85084a478822f5de81b","name":"Redacci\u00f3n Per\u00fa","description":"News published by the Pressenza bureau in Peru","url":"https:\/\/www.pressenza.com\/es\/author\/redaccion-peru\/"}]}},"place":"","original_article_url":"","_links":{"self":[{"href":"https:\/\/www.pressenza.com\/es\/wp-json\/wp\/v2\/posts\/1742228","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pressenza.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pressenza.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pressenza.com\/es\/wp-json\/wp\/v2\/users\/831"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pressenza.com\/es\/wp-json\/wp\/v2\/comments?post=1742228"}],"version-history":[{"count":0,"href":"https:\/\/www.pressenza.com\/es\/wp-json\/wp\/v2\/posts\/1742228\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pressenza.com\/es\/wp-json\/wp\/v2\/media\/1742229"}],"wp:attachment":[{"href":"https:\/\/www.pressenza.com\/es\/wp-json\/wp\/v2\/media?parent=1742228"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pressenza.com\/es\/wp-json\/wp\/v2\/categories?post=1742228"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pressenza.com\/es\/wp-json\/wp\/v2\/tags?post=1742228"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}